Cargando…
ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions
Ligands for ErbB receptors, including epidermal growth factor (EGF) and neuregulin-1, have a neurotrophic activity on midbrain dopaminergic neurons and are implicated in the pathophysiology of schizophrenia. Although ErbB kinase inhibitors ameliorate behavioral deficits of the schizophrenia model th...
Autores principales: | Mizuno, M, Sotoyama, H, Namba, H, Shibuya, M, Eda, T, Wang, R, Okubo, T, Nagata, K, Iwakura, Y, Nawa, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641415/ https://www.ncbi.nlm.nih.gov/pubmed/23632456 http://dx.doi.org/10.1038/tp.2013.29 |
Ejemplares similares
-
Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019) -
Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System
por: Sotoyama, Hidekazu, et al.
Publicado: (2023) -
ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease
por: Iwakura, Yuriko, et al.
Publicado: (2013) -
Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF
por: Sotoyama, Hidekazu, et al.
Publicado: (2011) -
On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity
por: Ledonne, Ada, et al.
Publicado: (2019)